Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?

Dirk Strumberg, Brian Schwartz, Holger W. Hirte et al.|European Journal of Cancer|2006

Cited by 149